Menu icon
A vertical stack of three evenly spaced horizontal lines.
Insider logo
The word "Insider".
Markets Insider logo
The word "Markets Insider".
Search markets
Search icon
A magnifying glass. It indicates, "Click to perform a search".
0
My Watchlist
Markets
Stocks
Indices
Commodities
Cryptocurrencies
Currencies
ETFs
News
Calendar icon
An icon in the shape of a calendar.
Economic
Earnings
Search markets
Search icon
A magnifying glass. It indicates, "Click to perform a search".
Search icon
A magnifying glass. It indicates, "Click to perform a search".
Markets Insider logo
The word "Markets Insider".
Close icon
Two crossed lines that form an 'X'. It indicates a way to close an interaction, or dismiss a notification.
Markets
The word Markets
Bonds
Funds
Pre-Market
Market Movers
Dow Jones Live
Your Portfolio
Stocks
The word Stocks
Stocks Finder
Market Movers
Index Constituents
Earnings Calendar
Dividends
Indices
The word Indices
Market Movers
Index Constituents
Dow Jones Live
S&P 500 Live
Nasdaq Live
World Map
Commodities
The word Commodities
News
Commodities Live
Gold
Oil
Copper
Cryptocurrencies
The word Cryptocurrencies
Bitcoin
Ethereum
Cryptocurrencies Live
Currencies
The word Currencies
News
Currencies Live
Currency Converter
EUR/USD
GBP/USD
US Dollar Index
ETFs
The word ETFs
News
ETF Finder
ETF Issuers
News
The word News
My Watchlist
Facebook Icon
The letter F.
Twitter icon
A stylized bird with an open mouth, tweeting.
LinkedIn icon
The word "in".
YouTube icon
A play button in the shape of a television screen.
Instagram icon
A stylized camera.
Insider logo
The word "Insider".
© 2023
Insider Inc. and
finanzen.net
GmbH (Imprint). All rights reserved.
Registration on or use of this site constitutes acceptance of our
Terms of Service
and
Privacy Policy.
Disclaimer
Accessibility
Commerce Policy
Advertising Policies
Made in NYC
Stock quotes by
finanzen.net
News for Coronado Biosciences Inc
Seeking Alpha
18d
Avenue stock surges ~15% on cash/stock licensing deal for neuromuscular disorder drug AJ201
Benzinga
20d
Why Smith Micro Software Shares Are Trading Lower By Over 46%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Seeking Alpha
40d
Fortress Biotech stock dips after pricing ~$13.9M stock offering
Seeking Alpha
96d
Fortress Bio jumps 15% after expanding licensing deal for gout therapy
Seeking Alpha
125d
Fortress Biotech Non-GAAP EPS of -$0.08 misses by $0.01, revenue of $16.5M misses by $5.13M
GlobeNewswire
125d
Fortress Biotech Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
GlobeNewswire
129d
Journey Medical Corporation Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
Seeking Alpha
130d
Notable earnings after Thursday's close
Seeking Alpha
130d
Fortress Biotech Q3 2022 Earnings Preview
GlobeNewswire
137d
Journey Medical Corporation to Announce Third Quarter 2022 Financial Results on November 10, 2022
EQS Group
165d
EQS-News: Fortress Bios Portfolio Of Marketed Drugs Could Soon See Three Additions
GlobeNewswire
166d
Fortress Biotech Announces Timing of Regular Monthly Dividend for October, November and December 2022 for its 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock
GlobeNewswire
167d
Journey Medical Corporation to Participate in Upcoming October 2022 Investor Conferences
GlobeNewswire
168d
Urica Therapeutics Appoints Seasoned Biotech Executive Jay D. Kranzler, M.D., Ph.D., as Chairman and Chief Executive Officer
GlobeNewswire
193d
Fortress Biotech to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
GlobeNewswire
202d
Journey Medical Corporation Announces 50% Enrollment Milestone Achieved in Phase 3 Clinical Trials Evaluating DFD-29 (Minocycline Modified Release Capsules 40 mg) for the Treatment of...
GlobeNewswire
220d
Fortress Biotech Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights
Seeking Alpha
220d
Fortress Biotech Non-GAAP EPS of -$0.10 misses by $0.03, revenue of $18.89M misses by $4.29M
GlobeNewswire
221d
Fortress Biotech Subsidiary Helocyte Announces Grant that Could Provide Over $20 Million from National Institute of Allergy and Infectious Diseases for Phase 2 Study of Triplex for Control of...
Seeking Alpha
221d
Fortress to get NIH funding for trial of Triplex vaccine to prevent CMV in liver transplant patients
GlobeNewswire
222d
Journey Medical Corporation Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights
Seeking Alpha
222d
Fortress Biotech GAAP EPS of -$0.43 misses by $0.19, revenue of $18.3M misses by $4.88M
Seeking Alpha
223d
Notable earnings after Tuesday's close
Benzinga
227d
Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2022
GlobeNewswire
229d
Journey Medical Corporation to Announce Second Quarter 2022 Financial Results on August 9, 2022
GlobeNewswire
241d
Fortress Biotech Appoints David Jin as Chief Financial Officer
Seeking Alpha
241d
David Jin is the new finance chief of Fortress Biotech
Seeking Alpha
279d
Mustang Bio updates interim data for blood cancer candidate
GlobeNewswire
293d
Fortress Biotech Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating Dotinurad for the Treatment of Gout in the United States
GlobeNewswire
300d
Journey Medical Corporation Announces Settlement Agreements Pertaining to QBREXZA®, AMZEEQ® and ZILXI® Patent Exclusivity
GlobeNewswire
301d
Journey Medical Corporation to Present at the B. Riley Securities 22nd Annual Institutional Investor Conference
GlobeNewswire
306d
Fortress Biotech to Participate in Two Upcoming May 2022 Investor Conferences
Seeking Alpha
310d
Catalyst watch: Twitter drama, high-profile Block and Caterpillar events, Jerome Powell talks
GlobeNewswire
311d
Fortress Biotech Reports First Quarter 2022 Financial Results and Recent Corporate Highlights
Seeking Alpha
311d
Fortress Biotech Non-GAAP EPS of -$0.07 misses by $0.08, revenue of $23.93M beats by $3.26M
GlobeNewswire
313d
Journey Medical Corporation Reports First Quarter 2022 Financial Results and Recent Corporate Highlights
GlobeNewswire
320d
Journey Medical Corporation to Announce First Quarter 2022 Financial Results on May 10, 2022
GlobeNewswire
347d
Fortress Biotech to Present at the 21st Annual Needham Virtual Healthcare Conference
GlobeNewswire
350d
Journey Medical Corporation to Present at the Virtual Fortress Biotech R&D Summit Hosted by B. Riley Securities
GlobeNewswire
353d
Fortress Biotech Announces Virtual Two-Day R&D Summit Hosted by B. Riley Securities on Tuesday, April 5 and Wednesday, April 6, 2022
GlobeNewswire
357d
Fortress Biotech Reports Record 2021 Financial Results and Recent Corporate Highlights
Seeking Alpha
357d
Fortress Biotech Non-GAAP EPS of $0.25 beats by $1.27, revenue of $68.79M misses by $26.25M
GlobeNewswire
361d
Journey Medical Corporation Reports Full-Year 2021 Financial Results and Recent Corporate Highlights
GlobeNewswire
364d
Fortress Biotech, Cyprium Therapeutics and Sentynl Therapeutics Announce CUTX-101, Copper Histidinate, Data to be Presented at 2022 American College of Medical Genetics Annual Clinical Genetics...
GlobeNewswire
366d
Journey Medical Corporation to Release Year End 2021 Financial Results and Provide Corporate Update on March 23, 2022
GlobeNewswire
368d
Journey Medical Corporation Announces First Patient Dosed in Phase 3 Clinical Trial Evaluating DFD-29 (Minocycline Modified Release Capsules 40 mg) for the Treatment of Rosacea
GlobeNewswire
376d
Fortress Biotech to Participate in Three March 2022 Investor Conferences
GlobeNewswire
376d
Journey Medical Corporation to Present at the 34th Annual ROTH Conference
GlobeNewswire
382d
Fortress Biotech Announces Virtual Two-Day Corporate Access Summit Hosted by B. Riley Securities on Tuesday, April 5 and Wednesday, April 6, 2022
GlobeNewswire
402d
QBREXZA® (Rapifort® Wipes 2.5%) Receives Manufacturing and Marketing Approval in Japan Triggering $2.5 Million Milestone Payment to Journey Medical Corporation
Page
Page
Page
1
Page
2
Page
3
Page
4
Page
5
Page
6
Page
Page
Find News
News
GO
